CAS 717824-30-1: Vidofludimus
Formula:C20H18FNO4
InChI:InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25)
InChI key:InChIKey=XPRDUGXOWVXZLL-UHFFFAOYSA-N
SMILES:C(NC1=C(F)C=C(C=C1)C2=CC(OC)=CC=C2)(=O)C3=C(C(O)=O)CCC3
Synonyms:- SC12267
- 1-Cyclopentene-1-carboxylic acid, 2-[[(3-fluoro-3′-methoxy[1,1′-biphenyl]-4-yl)amino]carbonyl]-
- Vidofludimus
- 2-((3-Fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl)carbamoyl)cyclopent-1-enecarboxylic acid
- 2-[[(3-Fluoro-3′-methoxy[1,1′-biphenyl]-4-yl)amino]carbonyl]-1-cyclopentene-1-carboxylic acid
Sort by
Found 4 products.
Vidofludimus
CAS:Vidofludimus (SC12267) (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).Formula:C20H18FNO4Purity:98.83% - 99.58%Color and Shape:SolidMolecular weight:355.36Vidofludimus
CAS:Vidofludimus is a cytotoxic drug that has been shown to have potent antiproliferative activity. It binds to the mitochondrial membrane potential, inhibiting the production of ATP and inducing apoptosis in cells. Vidofludimus has also been shown to be effective against autoimmune diseases, such as primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD). Vidofludimus inhibits the production of cytokines by inhibiting nuclear factor kappa-B (NF-κB), which is an important mediator in the immune response. Vidofludimus has been shown to inhibit the synthesis of nucleotides, which may contribute to its efficacy in treating kidney fibrosis. Vidofludimus is a chemical inhibitor that blocks protein synthesis through inhibition of polysomes in cells.Formula:C20H18FNO4Purity:Min. 95%Molecular weight:355.36 g/mol
